Cardinal Health, Inc. filed its Form 10-K for the fiscal year ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 11, 2026, covering operations across its Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution segments.

Key Highlights

  • Fiscal year end: The annual report covers the fiscal year ended June 30, 2026.
  • Shares outstanding: As of July 31, 2026, the company had 232,575,728 common shares outstanding.
  • Market value of non-affiliate holdings: The aggregate market value of voting stock held by non-affiliates on December 31, 2025, was $48,192,692,777.
  • Two reportable segments: The company reports financial results in the Pharmaceutical and Specialty Solutions segment and the Global Medical Products and Distribution segment, with remaining operations in Other.
  • Large accelerated filer: The company is classified as a large accelerated filer under SEC rules.
  • Internal controls attestation: The registered public accounting firm has filed a report and attestation on management's assessment of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act.

Cardinal Health Fiscal 2026 10-K: Segments, Share Count, and Key Disclosures

Cardinal Health, Inc. (NYSE:CAH), an Ohio corporation formed in 1979, describes itself in the filing as "a global healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home." The company is headquartered at 7000 Cardinal Place, Dublin, Ohio 43017.

According to the filing, Cardinal Health organizes its operations into two reportable segments. The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Global Medical Products and Distribution segment encompasses the company's medical products business. A third category, Other, includes Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight Logistics, which the filing states are not significant enough to require separate reportable segment disclosures.

The filing notes that its Management's Discussion and Analysis section addresses fiscal 2026 and fiscal 2025 items and year-over-year comparisons for those two periods. Comparisons between fiscal 2025 and fiscal 2024 are referenced to the company's prior annual report. The report also uses non-GAAP financial measures, which the filing states are reconciled to their most directly comparable GAAP measures in a dedicated section of the document. The filing includes forward-looking statements, which the company notes "are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied," as described in the Risk Factors section and Exhibit 99.1.

What Was Disclosed

Cardinal Health filed its fiscal year 2026 Form 10-K disclosing its two-segment structure, 232,575,728 shares outstanding as of July 31, 2026, a non-affiliate market capitalization of approximately $48.19 billion as of December 31, 2025, and its classification as a large accelerated filer.